5-fluorodopamine has been researched along with Parkinsonian Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arbizu, J; Blesa, J; Cavada, C; Collantes, M; García-García, D; Iglesias, E; Juri, C; Martí-Climent, J; Obeso, JA; Peñuelas, I; Prieto, E; Richter, JA; Rodríguez-Oroz, MC; Zubieta, JL | 1 |
Goldstein, DS; Tipre, DN | 1 |
1 trial(s) available for 5-fluorodopamine and Parkinsonian Disorders
Article | Year |
---|---|
Cardiac and extracardiac sympathetic denervation in Parkinson's disease with orthostatic hypotension and in pure autonomic failure.
Topics: Adult; Aged; Autonomic Nervous System; Autonomic Nervous System Diseases; Desipramine; Dopamine; Fluorine Radioisotopes; Heart Ventricles; Humans; Middle Aged; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Shy-Drager Syndrome; Sympathetic Nervous System | 2005 |
1 other study(ies) available for 5-fluorodopamine and Parkinsonian Disorders
Article | Year |
---|---|
Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study.
Topics: Animals; Brain Mapping; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Disease Models, Animal; Disease Progression; Dopamine; Dyskinesias; Female; Macaca fascicularis; Male; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Severity of Illness Index; Signal Processing, Computer-Assisted; Tetrabenazine | 2010 |